Chitosan nanoparticles: a promising system in novel drug delivery.
暂无分享,去创建一个
[1] Mohamed H. El-Shabouri,et al. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. , 2002, International journal of pharmaceutics.
[2] W. Tiyaboonchai,et al. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. , 2007, International journal of pharmaceutics.
[3] Miqin Zhang,et al. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery , 2006, International journal of nanomedicine.
[4] R. Jain,et al. Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.
[5] Manisha Chawla,et al. Chitosan: some pharmaceutical and biological aspects ‐ an update , 2001, The Journal of pharmacy and pharmacology.
[6] S. Aiba. Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated chitosans. , 1992, International journal of biological macromolecules.
[7] B. Sarmento,et al. Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery , 2007, Pharmaceutical Research.
[8] L. Illum,et al. Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models , 1996 .
[9] M. Alonso,et al. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers , 1997 .
[10] J. Tsibouklis,et al. Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. , 2003, Journal of pharmaceutical sciences.
[11] T. Kissel,et al. The depolymerization of chitosan: effects on physicochemical and biological properties. , 2004, International journal of pharmaceutics.
[12] G. Lee. Microparticulate systems for the delivery of proteins and vaccines , 1997 .
[13] P Couvreur,et al. Development of a new drug carrier made from alginate. , 1993, Journal of pharmaceutical sciences.
[14] B Larijani,et al. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] M. Davies,et al. Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems. , 2000, The Biochemical journal.
[16] H E Junginger,et al. Chitosan for mucosal vaccination. , 2001, Advanced drug delivery reviews.
[17] V. Dodane,et al. Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.
[18] J. Lehoux,et al. Some effects of chitosan on liver function in the rat. , 1993, Endocrinology.
[19] S. Davis,et al. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[20] P. G. Seferian,et al. Immune stimulating activity of two new chitosan containing adjuvant formulations. , 2000, Vaccine.
[21] V. Parameswaran,et al. Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates calcarifer) to protect from Vibrio (Listonella) anguillarum. , 2008, Fish & shellfish immunology.
[22] C. Fong,et al. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[23] Stefaan C. De Smedt,et al. Cationic Polymer Based Gene Delivery Systems , 2000, Pharmaceutical Research.
[24] Feng Xu,et al. Three-dimensional polymeric systems for cancer cell studies , 2007, Cytotechnology.
[25] C. Remuñán-López,et al. Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles , 1999, Pharmaceutical Research.
[26] Y Wang,et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[27] Yu-Hsin Lin,et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. , 2007, Biomacromolecules.
[28] I. Vural,et al. Preparation and In Vitro Evaluation of bFGF-Loaded Chitosan Nanoparticles , 2007, Drug delivery.
[29] H. Junginger,et al. Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs , 2001, Pharmaceutical Research.
[30] Y. Ikada,et al. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. , 2000, Drug delivery.
[31] Sinjan De,et al. Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[32] G. Luo,et al. Adsorption of diuretic furosemide onto chitosan nanoparticles prepared with a water-in-oil nanoemulsion system , 2005 .
[33] K. Leong,et al. Chitosan nanoparticles for oral drug and gene delivery , 2006, International journal of nanomedicine.
[34] M. Alonso,et al. Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery , 2006, Pharmaceutical Research.
[35] W. Park,et al. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. , 1995, Biomaterials.
[36] K. Leong,et al. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. , 2004, Biomaterials.
[37] Lisbeth Illum,et al. Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2) , 1994, Pharmaceutical Research.
[38] E. Leo,et al. Chitosan-Alginate Microparticles as a Protein Carrier , 2001, Drug development and industrial pharmacy.
[39] H E Junginger,et al. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[40] Bruno Sarmento,et al. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies , 2006 .
[41] A. Perkins,et al. Evaluation of the clearance characteristics of bioadhesive systems in humans. , 1999, International journal of pharmaceutics.
[42] B. Sarmento,et al. Development and Comparison of Different Nanoparticulate Polyelectrolyte Complexes as Insulin Carriers , 2006, International Journal of Peptide Research and Therapeutics.
[43] M. Alonso,et al. Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .
[44] V. Dodane,et al. Pharmaceutical applications of chitosan , 1998 .
[45] F. Hoppe-Seyler. Ueber Chitin und Cellulose , 1894 .
[46] H E Junginger,et al. Chitosan and its derivatives in mucosal drug and vaccine delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[47] G. Payne,et al. Chitosan-mediated and spatially selective electrodeposition of nanoscale particles. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[48] R. Müller. Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization, and In Vivo Distribution , 1991 .
[49] Per Artursson,et al. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells , 1996, Pharmaceutical Research.
[50] R. Bodmeier,et al. A Novel Approach to the Oral Delivery of Micro- or Nanoparticles , 1989, Pharmaceutical Research.
[51] Rakesh K. Sharma,et al. Pharmacoscintigraphic evaluation of polysorbate80-coated chitosan nanoparticles for brain targeting , 2005 .
[52] S. Davis,et al. Chitosan as a novel nasal delivery system for vaccines. , 2001, Advanced drug delivery reviews.
[53] R. Chen,et al. Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle , 2008 .
[54] Y. Murata,et al. Preparation of alginate gel beads containing chitosan nicotinic acid salt and the functions. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[55] Hui Xu,et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. , 2002, International journal of pharmaceutics.
[56] Tao Wang,et al. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. , 2005, Colloids and surfaces. B, Biointerfaces.
[57] M. Alonso,et al. Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines , 1997, Pharmaceutical Research.
[58] S. Neau,et al. In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. , 2002, Biomaterials.
[59] A. Bozkır,et al. Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics , 2004, Drug delivery.
[60] P. Couvreur,et al. Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. , 1980, European journal of cancer.
[61] T. Bettinger,et al. Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.
[62] S. Neau,et al. In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation. , 2001, Biomaterials.
[63] A. M. Dyer,et al. Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles , 2002, Pharmaceutical Research.
[64] Haliza Katas,et al. Development and characterisation of chitosan nanoparticles for siRNA delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[65] J. Kreuter,et al. Colloidal Drug Delivery Systems , 1994 .
[66] Jayanth Panyam,et al. Surfactant-polymer Nanoparticles: A Novel Platform for Sustained and Enhanced Cellular Delivery of Water-soluble Molecules , 2007, Pharmaceutical Research.
[67] K. Janes,et al. Chitosan nanoparticles as delivery systems for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[68] H. Tønnesen,et al. Alginate in Drug Delivery Systems , 2002, Drug development and industrial pharmacy.
[69] O. Kayser,et al. The impact of nanobiotechnology on the development of new drug delivery systems. , 2005, Current pharmaceutical biotechnology.
[70] M. Tabrizian,et al. Effect of experimental parameters on the formation of alginate–chitosan nanoparticles and evaluation of their potential application as DNA carrier , 2005, Journal of biomaterials science. Polymer edition.
[71] Rajesh Pandey,et al. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. , 2005, International journal of pharmaceutics.
[72] M. Rafiee-Tehrani,et al. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods. , 2008, International journal of pharmaceutics.
[73] Shirui Mao,et al. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[74] V. Sinha,et al. Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods , 2004, AAPS PharmSciTech.
[75] Robert Gurny,et al. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. , 1999, International journal of pharmaceutics.
[76] B. Sarmento,et al. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. , 2007, Journal of nanoscience and nanotechnology.
[77] A. Vila,et al. Design of biodegradable particles for protein delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[78] R. Pandey,et al. Polymer based drug delivery systems for mycobacterial infections. , 2004, Current drug delivery.
[79] K. Leong,et al. DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[80] C. Cho,et al. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[81] T. Okano,et al. Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[82] Xiaojun Ma,et al. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. , 2005, Carbohydrate research.
[83] F. Wang,et al. Designing chitosan-dextran sulfate nanoparticles using charge ratios , 2007, AAPS PharmSciTech.
[84] Maria José Alonso,et al. Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport , 2002, Pharmaceutical Research.
[85] K. Leong,et al. Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. , 2001, Biomacromolecules.
[86] P. Bhat,et al. The limiting role of mucus in drug absorption : drug permeation through mucus solution , 1995 .
[87] A. Vila,et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[88] R. Pandey,et al. Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. , 2006, The Indian journal of chest diseases & allied sciences.
[89] J. Hamman,et al. Evaluation of the Mucoadhesive Properties of N-Trimethyl Chitosan Chloride , 2003, Drug development and industrial pharmacy.
[90] L. Shi,et al. Adsorption of Neutral Proteinase on Chitosan Nano-Particles , 2007 .
[91] J. Mano,et al. Chitosan-Based Particles as Controlled Drug Delivery Systems , 2004, Drug delivery.
[92] Yoshiaki,et al. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .
[93] Y. Ikada,et al. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. , 1988, Journal of biomedical materials research.
[94] Yan Chen,et al. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide , 2003, Letters in Peptide Science.
[95] Harjinder Singh,et al. Preparation and characterization of nanoparticles formed by chitosan-caseinate interactions. , 2008, Colloids and surfaces. B, Biointerfaces.
[96] R. Muzzarelli. Chitosan-based dietary foods , 1996 .
[97] T. Okano,et al. Cell sheet engineering for myocardial tissue reconstruction. , 2003, Biomaterials.
[98] Hans E. Junginger,et al. Mucoadhesive Polymers in Peroral Peptide Drug Delivery. VI. Carbomer and Chitosan Improve the Intestinal Absorption of the Peptide Drug Buserelin In Vivo , 1996, Pharmaceutical Research.
[99] S. Hirota,et al. Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11. , 1998, Cancer letters.
[100] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.